Nhân ngày Quốc tế phụ nữ Việt Nam, bạn đã chuẩn bị những lời chúc nào tới mẹ chưa? Gợi ý cho bạn 10 lời cảm ơn dành tặng mẹ nhân ngày 20/10. Đảm bảo những lời chúc dưới đây rất ý nghĩa và sâu sắc sẽ khiến cho mẹ được tặng vô cùng xúc động.
Women in the UK will be able to purchase Gina 10 mg vaginal tablets without prescription from September from their local pharmacies, announced the Medicines
and Healthcare products Regulatory Agency (MHRA).
The Hormone Replacement Therapy (HRT) product, Gina 10 microgram vaginal tablets (containing estradiol) are used for the treatment of vaginal symptoms such as
dryness, soreness, itching, burning and uncomfortable sex caused by oestrogen deficiency in postmenopausal women aged 50 years and above who have not had a period
for at least one year.
The decision to reclassify these vaginal tablets follows a safety review by the MHRA, independent advice from the Commission on Human Medicines (CHM), and a public
consultation.
The UK regulator sought views from patients, pharmacists, prescribers and a wide range of stakeholders including the Royal College of Obstetricians & Gynaecologists,
the Faculty of Sexual & Reproductive Healthcare, the British Pharmacopoeia Commission and the British Menopause Society.
2017 ICD-10-CM for Physicians and Hospitals: With over 1,900 updates effective October 1, 2016, the 2017 ICD-10-CM for Physicians and Hospitals is jam-packed with critical features to secure your reimbursement in 2017.
Gear up for 2019 and take charge of diagnostic and inpatient procedures coding with TCI's Hospital Inpatient Coder Bundle that gets you ICD-10-CM for Physicians & Hospitals and ICD-10-PCS Complete Code Set at one low price.
Johnson & Johnson has made it to the list of top 10 most innovative companies in the world released by FOREX.com.
The US-based pharmaceutical company is the fourth most innovative company, scoring 8.23/10 in the innovation index.
Johnson & Johnson is the only pharmaceutical company making it to top 10 list, which makes it the world's most innovative pharmaceutical company in 2023.
The ranking is based on many factors such as the number of US-registered patents in 2022, the number of R&D expenses over the last 12 consecutive months and
their last reported intangible assets.
The health giant spent £37.16 billion on intangible assets (the second highest after Apple), £11.87 billion on R&D last year and registered 1,377 patents last year.
In this edition, "The 10 Smartest Healthcare Companies to Work for in 2019," we have enlisted the leading healthcare solution providers, who are the catalysts to technological advancements in this space. Owing to their remarkable contribution to the industry, we are stepping towards positive disruption to improve care and simultaneously improve the living for people.
The regulators have added 10 new products to the 'Drugs for which Discount is Not Deducted' (DND) list from Thursday (01 June).
Community Pharmacy England on behalf of its members had made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services
Authority (NHSBSA), resulting in the inclusion of 10 new products in the DND.
More than 610 products are granted DND status following checks made by Community Pharmacy England's dispensing & supply team over the past 3 years to ensure fair
reimbursement for our members.
The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff. Any
items covered by the 'Group Items' heading are not listed again individually in Part II.
"We will continue our work to assess whether other drugs and appliances fulfil the current DND entry requirements under either the 'Group' and 'Individual item'
criteria and make applications to NHSBSA and DHSC, on behalf of our members accordingly," said Community Pharmacy England.
Top 10 bone marrow transplant hospitals in India are dedicated to providing treatment to both domestic and international medical tourists at reasonable prices.
As an unprecedented demand for Lateral Flow Device (LFD) test kits continues through the Pharmacy Collect service, the UK Health Security Agency (UKHSA) is planning to distribute 10.5 million tests per week via Alliance Healthcare this month.
By the end of this week (January 8), the UKHSA aims to distribute more than 8 million tests to Alliance Healthcare - sole distributor to pharmacies.
The announcement comes after many in the pharmacy sector voiced concerns over shortage of test kits. Earlier this week, it emerged that Alliance Healthcare closed for four days shortly after receiving around 2.5 million tests on Christmas Eve.
Meanwhile, the UKHSA indicated that Alliance Healthcare has been delivering 86 per cent of its orders within 24 hours of the pharmacy order, nearly half of that on the same day.
Besides, a plan to switch on a Parcel Force delivery contingency is being finalised by UKHSA, which would enable supply of a further 3.5 million test kits.
For 11 years HospitalRecruiting has been a professional resource for healthcare job seekers and employers alike. Here are our top-performing articles of 2023.
Read more: https://www.hospitalrecruiting.com/blog/9166/top-10-blogs-of-2023/
#TOP10 #happynewyear2024 #healthcare #careeradvice #physicians #medicalnews
Customs officials at Mundra port in Gujarat's Kutch district, India, recently seized approximately 6.8 million Tramadol tablets valued at Rs 110 crore
(around GBP 10.2 million).
The tablets were discovered in two export containers bound for Sierra Leone and Niger in West Africa.
Tramadol, an opioid pain medication, was classified as a psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act (NDPS Act) in 2018 and
its export is now restricted.
This synthetic opioid drug has gained notoriety in recent times as the "Fighter Drug" after it was reported that ISIS fighters used it to stay awake for long
hours, said a PIB release on Monday.
It is reportedly in high demand in African nations like Nigeria, Ghana, etc.
The Mundra Customs seizure is one of the largest seizures of Tramadol since it was notified under the NDPS Act, said the release.
Ask an Expert 2016 - The book contains answers to more 1,400 questions asked on our online forum, curated as a helpful guide for cracking tough coding situations. The guide answers questions on ICD 10 coding, documentation and CPT questions arising from CPT 2017 professional edition spiral bound guide.
Khi cho con đi du lịch rất nhiều mẹ e ngại vì sợ con quấy khóc, không đủ sức đề kháng dễ sinh bệnh trong môi trường mới,…
Tuy nhiên lại muốn gia đình có những khoảnh khắc đẹp bên nhau thì việc cần thiết là phải chuẩn bị thật đầy đủ những đồ dùng nên mang theo. Trong bài dưới đây, iMediCare sẽ gợi ý 10 vật dụng cần mang theo khi cho bé đi du lịch.
National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal
immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July).
Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were
immediately referred on the suspected cancer pathway.
The new draft guidance will now see everyone receive a FIT.
A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with
10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation.
Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer.
The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer.
The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist.
The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent
referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.
The Department of Health and Social Care (DHSC) has confirmed on Thursday (15 June) that everyone aged 60 and over will continue to receive free prescriptions.
In response to a consultation launched by the DHSC in 2021 looking at whether the age free prescriptions become available should be aligned with the State Pension
age, which is currently 66, the government decided to freeze the age at 60.
Minister for Health Neil O'Brien said: "This government recognises the pressures with the cost of living caused by Russia's invasion of Ukraine. That's why we are
providing cost of living help worth £3,300 on average per household over last year and this, among the most generous help anywhere in Europe.
"It's also why we have decided to maintain the prescription exemption age where it is. Nine out of 10 prescriptions are already free at the point of use and on top
of that we also provide financial help to others on low incomes who don't automatically get prescriptions for free.
"Prescription charge exemptions will also remain in place for those aged under 16 or aged 17 and 18 but in full time education, while those in receipt of certain
benefits can also receive free prescriptions," said DHSC.
For those who do not qualify for an exemption or the NHS Low Income Scheme, prepayment certificates (PPC) are available to help with frequent prescriptions should
they be required.
The annual PPC can be paid for through 10 instalments. This means people can have as many prescription items as needed for just over £2 per week.
Denmark's Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment achieved up to 14.9% weight loss in a mid-stage trial, lining up
a potential contestant in the booming obesity drug market.
In a statement on Wednesday (May 10), the partners said that the Phase II dose-finding trial met its primary endpoint of weight loss after 46 weeks.
Paola Casarosa, head of therapeutic areas at Germany's Boehringer Ingelheim told Reuters the partners are in discussion with regulators about the design of a
planned follow-up trial in the third and last phase of testing.
The enormous demand for weight-loss treatments such as Novo Nordisk's Wegovy, or potentially Eli Lilly's Mounjaro, could support as many as 10 competing products
with annual sales reaching up to $100 billion within a decade, mostly in the United States, industry executives and analysts said.
Lilly said about a year ago that Mounjaro was shown to reduce up to 22.5% in weight after 72 weeks of treatment in a much larger late-stage trial.
We are over the moon to break the news that your favourite health supplement brand in India got recognition as the "Top 10 Best Nutraceuticals Startups In India - 2022.
Thanks to the NHS primary care access recovery plan, more than 23 million people can now view test results and check their consultation notes online without
needing to contact their GP practice.
NHS England on Monday (4 December) announced that over 81 GP practices in England (more than four in five) are now giving patients access to their new health
records online through the NHS App.
In May, the NHS announced the primary care access recovery plan setting a target of 9 in 10 GP practices offering patients access to their records through the
NHS App by March 2024.
By making access to healthcare easier and quicker, the NHSE also aims to free up to 10 million GP appointments a year by next winter.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on plans to reclassify a locally-applied hormone replacement
therapy product to treat the cause and relieve the symptoms of vaginal atrophy.
The MHRA is proposing that Gina 10 microgram vaginal tablets, containing oestradiol, be made available over the counter as a "self care" product, under the
supervision of a pharmacist.
The Commission on Human Medicines too has advised that the application by Novo Nordisk, which is used to treat vaginal dryness, caused by oestrogen deficiency in
postmenopausal women, can be made available as a pharmacy (P) medicine.
The MHRA has been asking GPs, pharmacists and members of the public for their opinions on whether the tablets can be made available to women aged 50 and over who
have not had a period for at least a year.
If the reclassification goes ahead, pharmacists will be given training materials and a checklist to help them supply the medicine safely.